Micron Technology to Report Fiscal First Quarter Results on December 21, 2016
Nov 22, 2016 21:05 pm UTC| Business
BOISE, Idaho, Nov. 22, 2016 -- Micron Technology, Inc. (NASDAQ:MU) today announced that it will hold its fiscal first quarter earnings conference call on Wednesday, December 21, 2016 at 2:30 p.m. MT. A live webcast of...
Novavax to Present at the 28th Annual Piper Jaffray Healthcare Conference
Nov 22, 2016 21:05 pm UTC| Business
GAITHERSBURG, Md., Nov. 22, 2016 -- Novavax, Inc., (Nasdaq:NVAX) today announced Stanley C Erck, President and Chief Executive Officer, will present at the 28th Annual Piper Jaffray Healthcare Conference. Conference...
francesca’s® Announces Reporting Date for Third Quarter Fiscal Year 2016 Financial Results
Nov 22, 2016 21:05 pm UTC| Business
HOUSTON, Nov. 22, 2016 -- Francesca’s Holdings Corporation (NASDAQ:FRAN) today announced plans to report third quarter fiscal year 2016 financial results on Tuesday, December 6, 2016, before the market opens. The...
Fox Factory Holding Corp. Announces Closing of Secondary Public Offering
Nov 22, 2016 21:05 pm UTC| Business
SCOTTS VALLEY, Calif., Nov. 22, 2016 -- Fox Factory Holding Corp. (NASDAQ:FOXF) (the “Company”), today announced the closing of the previously announced secondary public offering of 4,025,000 shares of the Company’s...
Otonomy to Present at Piper Jaffray Healthcare Conference
Nov 22, 2016 21:05 pm UTC| Business
SAN DIEGO, Nov. 22, 2016 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that...
Phase 3 study with filgotinib initiated in Crohn's disease
Nov 22, 2016 21:04 pm UTC| Business
MECHELEN, Belgium, Nov. 22, 2016 -- Galapagos NV (Euronext NASDAQ: GLPG) reports the first dosing of a patient in the DIVERSITY Phase 3 study with filgotinib in Crohn's disease (CD). The start of the DIVERSITY study...
Achaogen Announces New Employment Inducement Grants
Nov 22, 2016 21:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 22, 2016 -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections,...